Mr Žilvinas Kvietkus > Cobalt > Vilnius, Lithuania > Lawyer Profile

Cobalt
Lvivo 25
09320 Vilnius
Lithuania

Work Department

Life sciences and Pharmaceutical law, Corporate and Intellectual property and related Dispute resolution

Position

Žilvinas Kvietkus is a Partner at COBALT Lithuania and Head of Corporate Transactions Department.
During more than 20 years legal practice Žilvinas Kvietkus has advised on a wide range of pharmaceutical work and possesses extensive experience in the Lithuanian and EU pharmaceutical sector. Mr Kvietkus has acted for numerous clients in many significant cases related to copyrights, trademarks and patents, in addition he has provided extensive counselling in M&A transactions involving pharmaceutical, telecoms and other regulated sectors. Other specialisations include labour and commercial laws.

Career

Partner at COBALT Lithuania (since 2004)

Languages

Lithuanian, English, Russian

Memberships

Since 2000 Member of the Lithuanian Bar Association
Member of the International Bar Association (IBA)

Education

1996 Faculty of Law, Vilnius University, Master´s Degree in Law
1996 Studies at Oxford University / George Washington University, Faculty of Law
1995 Studies at University of Stockholm, Faculty of Law, Sweden

Lawyer Rankings

Lithuania > Commercial, corporate and M&A

Advising a wide range of local and multinational clients, Cobalt is highly active in a plethora of major M&A spanning from defence and aerospace to maritime, transportation, energy, and IT. The firm is also noted for its strong cross-border capabilities, assisting acquisitions both into and out of Lithuania. A highly experienced team, managing partner Irmantas Norkus has broad transactional, banking, and competition experience, as does partner Elijus Burgis . Heading the M&A practice group is corporate and private equity expert Juozas Rimas , meanwhile life science and EU pharmaceutical expert Zilvinas Kvietkus also supports. Akvilė Bosaitė, co-head of the banking and finance practice, is another notable expert on M&A.

Lithuania > TMT

(Hall of Fame)

Žilvinas KvietkusCobalt

Representing major technology giants Huawei and Apple, as well as payment service providers and pharmaceutical companies, Cobalt‘s team has a solid track record in handling prominent TMT matters in Lithuania. Practice head Zilvinas Kvietkus stands out for his ‘exceptional knowledge of pharmaceutical business‘, and is adept at advising on contentious and non-contentious TMT cases in the sector. Renata Vasiliauskienė focuses on data protection, licensing, and regulatory compliance, and managing associate Julija Beldeninovienė handles contentious mandates. Juras Žymančius is another key contact.

Lithuania > Employment

Cobalt assists global household names including Amazon, Google, and FedEx, with compliance with local employment regulations, especially issues relating to recent changes to the Labour Code. The firm has also seen several mandates regarding employee disputes, reorganisations, employee transfers, and migration issues. The employment team is spearheaded by Jovita Valatkaitė, who provides guidance on a broad spectrum of employment and relocation matters, and also has niche expertise in employee data protection work. Eglė Gliaudelytė is central at associate level, while legal counsel Dalia Foigt-Norvaišienė  and Žilvinas Kvietkus also contributing to the practice.

Lithuania > Intellectual property

(Leading partners)

Žilvinas KvietkusCobalt

Cobalt‘s IP team particularly stands out for its focus on the healthcare, pharmaceuticals and life science sectors, where it regularly represents multinational industry giants in patent protection, infringement, and enforcement cases. Alongside these areas, the IP practice also provides advice in the fields of data protection and IT. The practice is led by Žilvinas Kvietkus, who has extensive experience advising on copyright, trade mark and patent issues in the Lithuanian and EU pharmaceuticals sectors. Managing associate Julija Beldeninovienė is another core member of the team with knowledge of the pharmaceuticals, infotech, and IP spaces.